Skip to content

Chest CT Scan in Pulmonary Mucormycosis: Prognostic Value

Chest CT Scan in Pulmonary Mucormycosis: Prognostic Value

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07339800
Acronym
RadioMucor
Enrollment
80
Registered
2026-01-14
Start date
2025-09-18
Completion date
2026-09-19
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Mucormycosis

Keywords

Pulmonary Mucormycosis, Fungal infections

Brief summary

Invasive pulmonary fungal infections caused by Mucorales are rare but severe and rapidly progressive, affecting immunocompromised patients. The role of chest imaging in their diagnosis is well established in the 2020 EORTC/MSGERC criteria, and its use is almost systematic. However, the progression of lung parenchymal involvement and any potential prognostic radiological patterns in the follow-up of these infections are less well understood. This research aims to identify imaging characteristics predictive of favorable or unfavorable outcomes in infected patients, in order to better tailor follow-up and therapeutic options.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 years or older * Treated at Strasbourg University Hospital between January 1, 2009, and June 3, 2025 * With a diagnosis of probable or proven invasive pulmonary infection with Mucorales according to the 2020 EORTC/MSGERC criteria * Having undergone at least one CT scan including the thoracic region

Exclusion criteria

* No CT scan including the thoracic region * No diagnosis of probable or proven invasive pulmonary infection with Mucorales (EORTC/MSGERC 2020 criteria)

Design outcomes

Primary

MeasureTime frameDescription
Death rate in patients with probable or proven invasive Mucorales infectionDay 15 after infectionDeath rate at day 15 in patients with probable or proven invasive Mucorales infection

Countries

France

Contacts

Primary Contactbaptiste Hoellinger, MD
baptiste.hoellinger@chru-strasbourg.fr33 3 69 55 05 45

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026